Introduction
The retina is a vital component of the visual system and one of the most complex tissues in the body. It is a thin, light-sensitive layer that sits at the back of the eye, much like film in a camera. It works by capturing light and converting it into electrical impulses, which are then interpreted by the brain to create our view of the world.1 Healthy retinas are important for proper vision, and various disorders can impair the function of these delicate structures.2 These range from common diseases like diabetic retinopathy, which results from prolonged high blood sugar levels to less common genetic disorders like Stargardt disease. These conditions present unique challenges, making it important to understand retinal health and disease if we are to maintain vision and improve outcomes for sufferers. Through increased awareness and ongoing research, we can better understand these diseases, leading to more effective treatments and preventative measures that safeguard eye health.
Common retinal disorders
Retinopathy
Retinopathy refers to a group of conditions that impair the function of the retina. The most notable forms of the disease are diabetic and hypertensive retinopathy.
- Diabetic retinopathy: this disorder results from prolonged high blood sugar levels that damage the tiny blood vessels within the retina, leading to swelling, hemorrhages, and in severe cases, the formation of new but fragile vessels that can bleed easily3,4
- Hypertensive retinopathy: this is caused by high blood pressure, which can lead to retinal vascular constriction (narrowing of the retinal blood vessels), optic disc edema (swelling of the optic disc), and retinal hemorrhages (bleeding from the vessels in the retina)
Common symptoms of retinopathy include blurred vision, spots or dark strings floating in the vision (floaters), and vision loss. Diagnosis is typically made through a comprehensive eye exam including techniques like fundus photography (where images of the back of the eye are taken using specialist equipment), optical coherence tomography, and fluorescein angiography to view any damage in detail by using a special dye to look at the blood vessels in your eyes. The disease is usually managed by controlling the underlying diabetes or hypertension and may include laser therapy to seal or shrink leaking blood vessels, injections to reduce swelling and inhibit growth of abnormal vessels, and surgery for advanced cases. These are also new pharmaceutical products in development, and gene therapy is being actively discussed for diabetic retinopathy.4
Retinal detachment
Retinal detachment is a critical condition where the retina peels away from its underlying supportive tissues, cutting off its blood supply and leading to potential vision loss if not treated promptly.5 It commonly manifests in three forms: rhegmatogenous, tractional, and exudative. Rhegmatogenous retinal detachment is the most common type, caused by a break or tear in the retina that allows fluid to accumulate underneath. Tractional detachment is often seen in people with proliferative diabetic retinopathy where scar tissue creates traction on the retina, pulling it away. Exudative detachment occurs without tears or breaks, typically due to inflammation or injury causing fluid accumulation beneath the retina. Symptoms can include an increase in floaters, flashes of light, and a shadow or curtain descending over the field of vision. Treatment involves various surgical procedures such as pneumatic retinopexy, scleral buckling, or vitrectomy, depending on the type and extent of the detachment.
Macular degeneration
Macular degeneration primarily affects the macula, the central part of the retina responsible for high-resolution vision that we use in activities like reading and driving. It typically presents in two forms: dry (atrophic) and wet (neovascular).6 In dry macular degeneration, thinning of the macula and accumulation of drusen (tiny yellowish deposits) are usually seen, leading to gradual loss of central vision. Wet macular degeneration is more severe and involves the growth of abnormal blood vessels under the retina that leak fluid or blood, rapidly impairing vision.
There are a few main risk factors for macular degeneration:
- Aging: age-related macular degeneration (AMD) is a particularly pressing research area due to the aging global population7,8
- Genetics: several genetic pathways can affect the risk of macular degeneration and knowing how to predict risk based on genetic analysis is an area of ongoing research
- Smoking: smoking more than 20 cigarettes in a day has been shown to dramatically increase risk9
- High blood pressure: this is a known risk factor for AMD but is highly influenced by age and smoking (older people and smokers also tend to have high blood pressure)10
Treatment options for macular degeneration depend largely on the form of the disease. Dietary supplements and lifestyle changes can sometimes slow the progression of dry macular degeneration, whereas wet macular degeneration is often treated using injections of anti-VEGF agents to slow vascular growth, laser therapy, or photodynamic therapy. Regular monitoring through eye exams is critical to catch and manage this condition.
Inherited retinal disorders
Retinitis pigmentosa
Retinitis pigmentosa is a genetic disorder that causes the photoreceptors in the retina (rods and cones – the cells that respond to light) to deteriorate over time.11 The rod cells are affected first, leading to problems with night vision and peripheral vision. As the disease progresses, the cone cells can also be affected, leading to loss of detailed vision, colour discrimination, and facial recognition.
Retinitis pigmentosa is diagnosed using various eye exams. The standard tests include the following:
- Visual field testing: this assesses the extent of peripheral vision loss
- Electroretinography: to measure the electrical activity of photoreceptors in response to light
- Optical coherence tomography: this allows the clinician to look at the layers of the retina in detail
- Genetic testing: in recent years, this has been increasingly used to confirm the diagnosis and to identify specific genetic changes that might explain the disease. This information can help doctors to predict how the disease might progress over time and to assess whether the patient might benefit from gene therapies12
Retinitis pigmentosa is not curable, but its progress can be slowed. Some studies have shown that vitamin A supplementation can slow progression. Gene therapy and retinal implants are cutting-edge treatments that offer a lot of hope for the future. Low vision aids, such as magnifiers and text-to-speech software, and adaptations to home and work environments can significantly improve daily functioning and quality of life. Regular follow-ups with eye care professionals help monitor the disease progression and manage associated conditions.
Stargardt disease
Stargardt disease is a genetic condition that causes progressive vision loss that usually starts in childhood.13,14 It mostly affects the macula, the central part of the retina responsible for detailed vision. Because it affects this important part of the retina, the disease can have a big impact on quality of life. The disorder is usually diagnosed through comprehensive eye exams, which can reveal characteristic changes in the retina. Genetic testing is used to confirm the diagnosis and try to confirm which specific genetic mutations are causing the issues. Like many genetic diseases, Stargardt is not curable, so treatment usually focuses on low vision aids to enhance remaining vision and adopting protective measures such as wearing sunglasses to shield the eyes from UV light, which can exacerbate damage. Regular monitoring is essential to adapt interventions as the condition progresses.
Other inherited retinal disorders
Additional inherited disorders include choroideremia, cone-rod dystrophy, and Usher syndrome, each with unique symptoms and genetic causes. Emerging treatments like gene therapy offer hope.
Prevention and treatment of retinal disorders
Prevention and early detection are very important for preventing some of the negative outcomes that come with retinal disorders. Here are some critical steps to consider:
- Regular eye exams: these exams are particularly crucial for people with known risk factors such as diabetes, hypertension, or a family history of retinal disorders. Early detection through routine screenings can allow clinicians to prevent or slow the progression of eye diseases
- Lifestyle modifications:
- Diet: maintaining a balanced diet rich in vitamins A, C, and E, zinc, lutein, and omega-3 fatty acids can support retinal health15
- Exercise: regular physical activity can help control conditions like diabetes and hypertension, reducing the risk of diabetic retinopathy
- Smoking cessation: smoking is a significant risk factor for many eye conditions, including age-related macular degeneration
- Protective measures:
- UV-blocking sunglasses: protecting the eyes from UV rays can mitigate the risk of retinal damage and is especially important for people with light sensitivity or who are undergoing certain treatments that increase UV sensitivity
- Safety eyewear: protective eyewear during sports or industrial activities can prevent traumatic injuries to the eyes
- Genetic testing and counseling: for inherited retinal disorders, genetic testing can identify mutations that may increase the risk of developing specific conditions.16 Genetic counselors can then convey this information to patients and their families to inform them about the risk of transmitting conditions to children, available treatments, and ongoing clinical trials that may be appropriate
Implementing these preventative measures and seeking early intervention are instrumental in maintaining eye health and preventing the onset or progression of debilitating retinal disorders.
Summary
Eye health is essential for clear vision and overall quality of life. Regular health screenings and avoiding risk factors for retinal disorders can significantly reduce the likelihood of developing one of these potentially life-altering problems. Early detection and appropriate management are the best ways to deal with these conditions, and can ensure that individuals are able to lead fulfilling lives.
References
- Kolb H. Simple anatomy of the retina. In: Kolb H, Fernandez E, Nelson R, editors. Webvision: The Organization of the Retina and Visual System [Internet]. Salt Lake City (UT): University of Utah Health Sciences Center; 1995 [cited 2024 May 3]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK11533/
- Landau K, Kurz-Levin M. Retinal disorders. Handb Clin Neurol. 2011;102:97–116.
- Fung TH, Patel B, Wilmot EG, Amoaku WM. Diabetic retinopathy for the non-ophthalmologist. Clin Med (Lond). 2022 Mar;22(2):112–6.
- Tan TE, Wong TY. Diabetic retinopathy: Looking forward to 2030. Front Endocrinol (Lausanne). 2022;13:1077669.
- Steel D. Retinal detachment. BMJ Clin Evid. 2014 Mar 3;2014:0710.
- Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U. Age-related macular degeneration: a review. JAMA. 2024 Jan 9;331(2):147–57.
- Guymer RH, Campbell TG. Age-related macular degeneration. Lancet. 2023 Apr 29;401(10386):1459–72.
- Thomas CJ, Mirza RG, Gill MK. Age-related macular degeneration. Med Clin North Am. 2021 May;105(3):473–91.
- van Lookeren Campagne M, LeCouter J, Yaspan BL, Ye W. Mechanisms of age-related macular degeneration and therapeutic opportunities. J Pathol. 2014 Jan;232(2):151–64.
- Kuan V, Warwick A, Hingorani A, Tufail A, Cipriani V, Burgess S, et al. Association of smoking, alcohol consumption, blood pressure, body mass index, and glycemic risk factors with age-related macular degeneration: a mendelian randomization study. JAMA Ophthalmol. 2021 Dec 1;139(12):1299–306.
- Liu W, Liu S, Li P, Yao K. Retinitis pigmentosa: progress in molecular pathology and biotherapeutical strategies. Int J Mol Sci. 2022 Apr 28;23(9):4883.
- Daiger SP, Sullivan LS, Bowne SJ. Genes and mutations causing retinitis pigmentosa. Clin Genet. 2013 Aug;84(2):132–41.
- Piotter E, McClements ME, MacLaren RE. Therapy approaches for stargardt disease. Biomolecules. 2021 Aug 9;11(8):1179.
- Tanna P, Strauss RW, Fujinami K, Michaelides M. Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options. Br J Ophthalmol. 2017 Jan;101(1):25–30.
- Sajovic J, Meglič A, Glavač D, Markelj Š, Hawlina M, Fakin A. The role of vitamin a in retinal diseases. Int J Mol Sci. 2022 Jan 18;23(3):1014.
- Schneider N, Sundaresan Y, Gopalakrishnan P, Beryozkin A, Hanany M, Levanon EY, et al. Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities. Prog Retin Eye Res. 2022 Jul;89:101029.